Matches in DBpedia 2016-04 for { ?s ?p "Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir and elbasvir with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis : a randomised, open-label phase 2 trial" }
Showing triples 1 to 1 of
1
with 100 triples per page.
- s0140-6736(14)61795-5 title "Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir and elbasvir with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis : a randomised, open-label phase 2 trial".